Cogent Biosciences, Inc.COGTNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+30.7%
5Y CAGR+5.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+30.7%/yr
vs +25.9%/yr prior
5Y CAGR
+5.2%/yr
Recent acceleration
Acceleration
+4.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $312.01M | +217.8% |
| 2024 | $98.17M | +84.4% |
| 2023 | $53.23M | -61.9% |
| 2022 | $139.89M | -36.3% |
| 2021 | $219.68M | -9.3% |
| 2020 | $242.19M | +547.2% |
| 2019 | $37.42M | -32.8% |
| 2018 | $55.67M | +96.9% |
| 2017 | $28.27M | -31.6% |
| 2016 | $41.32M | - |